STAAR Surgical (STAA)
(Delayed Data from NSDQ)
$47.11 USD
-0.23 (-0.49%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $47.05 -0.06 (-0.13%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth D Momentum C VGM
Staar Surgical (STAA) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$50.33 | $60.00 | $40.00 | 6.32% |
Price Target
Based on short-term price targets offered by nine analysts, the average price target for Staar Surgical comes to $50.33. The forecasts range from a low of $40.00 to a high of $60.00. The average price target represents an increase of 6.32% from the last closing price of $47.34.
Analyst Price Targets (9 )
Broker Rating
Staar Surgical currently has an average brokerage recommendation (ABR) of 1.92 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 13 brokerage firms. The current ABR compares to an ABR of 1.92 a month ago based on 13 recommendations.
Of the 13 recommendations deriving the current ABR, seven are Strong Buy, representing 53.85% of all recommendations. A month ago, Strong Buy represented 53.85%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 7 | 7 | 7 | 6 | 6 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 6 | 6 | 6 | 7 | 7 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.92 | 1.92 | 1.92 | 2.08 | 2.08 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
6/11/2024 | BTIG | Ryan Zimmerman | Hold | Strong Buy |
5/9/2024 | Not Identified | Not Identified | Hold | Hold |
5/8/2024 | Piper Sandler | Matthew O'Brien | Hold | Hold |
4/11/2024 | Mizuho SecuritiesUSA | Anthony Petrone | Strong Buy | Strong Buy |
4/8/2024 | Canaccord Genuity | William J Plovanic | Hold | Hold |
4/4/2024 | William Blair | Margaret Kaczor | Hold | Strong Buy |
4/4/2024 | Needham & Company | David Saxon | Hold | Hold |
3/11/2024 | Not Identified | Not Identified | Hold | Strong Buy |
2/19/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
1/16/2024 | Stephens | George Sellers | Strong Buy | Strong Buy |
9/15/2023 | The Benchmark Company | Bruce D Jackson | Strong Buy | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.92 |
ABR (Last week) | 1.92 |
# of Recs in ABR | 13 |
Average Target Price | $50.33 |
LT Growth Rate | NA |
Industry | Medical - Dental Supplies |
Industry Rank by ABR | 77 of 252 |
Current Quarter EPS Est: | 0.25 |